Data / Form D filings / Thrive Bioscience, Inc.
Thrive Bioscience, Inc.: Form D filings
Thrive Bioscience, Inc., a biotechnology company in Wakefield, MA, filed 4 Form D notices with the SEC between 2015 and 2017. The latest, on August 28, 2017, reports $1.8 million sold of a $2.5 million offering to 21 investors.
Find out what Thrive Bioscience, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 11 Audubon Road, Wakefield, MA, 01880
- Phone
- (978) 720-8046
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1642601
The full lists. Form D filings in Massachusetts: 1,533 rows, $76.65, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2017 | New notice | $2,500,000 | $1,801,885 | $698,115 | 21 | May 19, 2017 | sec.gov |
| Mar 7, 2017 | New notice | $10,000,000 | $7,150,000 | $2,850,000 | 36 | Dec 30, 2016 | sec.gov |
| Dec 11, 2015 | New notice | $2,175,000 | $2,175,000 | $0 | 20 | Nov 25, 2015 | sec.gov |
| May 15, 2015 | New notice | $4,000,000 | $3,257,589 | $742,411 | 24 | Apr 30, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Thomas Forest Farb | Executive Officer, Director | |
| Michael Philippe Finney | Director | |
| Brock Philippe Reeve | Director | |
| Alan Philippe Blanchard | Executive Officer, Director | |
| Guy Philippe Broadbent | Director |
Other biotechnology companies in Massachusetts that filed recently
- Zai Lab Ltd $249.9 million · Nov 9, 2026
- AI3 Bio, Inc. offering · Nov 4, 2026
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
Every Form D from the week of Aug 28, 2017 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Thrive Bioscience, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.